ISIN | LU0953041174 |
---|---|
Valor Number | 21812702 |
Bloomberg Global ID | |
Fund Name | Pictet - Europe Index -I dy EUR |
Fund Provider |
Pictet Asset Management S.A.
Genève, Switzerland Phone: +41 58 323 10 24 www.assetmanagement.pictet |
Fund Provider | Pictet Asset Management S.A. |
Representative in Switzerland |
Pictet Asset Management S.A. Genève 73 Phone: +41 58 323 30 00 |
Distributor(s) |
Credit Suisse AG Zürich Phone: +41 44 333 11 11 UBS AG Zürich Phone: +41 44 234 11 11 Vontobel Fonds Services AG Zürich Phone: +41 58 283 74 77 |
Asset Class | Equities |
EFC Category | Equity Advanced Europe |
Distribution Policy | Distribution |
Home Country | Luxembourg |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The investment objective of the fund is to achieve a performance comparable to the reference index. The Fund aims for the full physical replication of the MSCI Europe Index (the “Benchmark Index”). |
Peculiarities |
Current Price * | 240.16 EUR | 01.08.2025 |
---|---|---|
Previous Price * | 244.76 EUR | 31.07.2025 |
52 Week High * | 249.28 EUR | 03.03.2025 |
52 Week Low * | 208.74 EUR | 09.04.2025 |
NAV * | 240.16 EUR | 01.08.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 1,271,140,110 | |
Unit/Share Assets *** | 31,344,314 | |
Trading Information SIX |
YTD Performance | +7.34% |
31.12.2024 - 01.08.2025
31.12.2024 01.08.2025 |
---|---|---|
YTD Performance (in CHF) | +6.41% |
31.12.2024 - 01.08.2025
31.12.2024 01.08.2025 |
1 month | -0.95% |
01.07.2025 - 01.08.2025
01.07.2025 01.08.2025 |
3 months | +2.24% |
01.05.2025 - 01.08.2025
01.05.2025 01.08.2025 |
6 months | +1.73% |
03.02.2025 - 01.08.2025
03.02.2025 01.08.2025 |
1 year | +7.09% |
02.08.2024 - 01.08.2025
02.08.2024 01.08.2025 |
2 years | +15.49% |
02.08.2023 - 01.08.2025
02.08.2023 01.08.2025 |
3 years | +22.41% |
02.08.2022 - 01.08.2025
02.08.2022 01.08.2025 |
5 years | +49.77% |
03.08.2020 - 01.08.2025
03.08.2020 01.08.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
SAP SE | 2.52% | |
---|---|---|
ASML Holding NV | 2.49% | |
Nestle SA | 2.06% | |
Novartis AG Registered Shares | 1.83% | |
Roche Holding AG | 1.81% | |
Novo Nordisk AS Class B | 1.77% | |
AstraZeneca PLC | 1.71% | |
HSBC Holdings PLC | 1.70% | |
Shell PLC | 1.67% | |
Siemens AG | 1.54% | |
Last data update | 30.06.2025 |
TER *** | 0.30% |
---|---|
TER date *** | 31.03.2025 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.30% |
Ongoing Charges *** | 0.31% |
SRRI ***
|
|
SRRI date *** | 30.06.2025 |